US Stock MarketDetailed Quotes

TENX Tenax Therapeutics

Watchlist
  • 6.0100
  • +0.0700+1.18%
Close Dec 11 16:00 ET
  • 6.1000
  • +0.0900+1.50%
Post 16:36 ET
20.49MMarket Cap-0.46P/E (TTM)

Tenax Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
118.14%4.62M
197.05%3.67M
153.88%3.91M
-25.50%8.23M
30.78%3.34M
-27.42%2.12M
-56.81%1.24M
-43.37%1.54M
-66.23%11.05M
-20.46%2.55M
Selling and administrative expenses
43.30%1.51M
29.49%1.34M
-3.22%1.23M
-11.81%5.01M
15.63%1.64M
-23.65%1.05M
-22.37%1.04M
-17.33%1.27M
-25.14%5.68M
-38.17%1.42M
-General and administrative expense
43.30%1.51M
29.49%1.34M
-3.22%1.23M
-11.81%5.01M
15.63%1.64M
-23.65%1.05M
-22.37%1.04M
-17.33%1.27M
-25.14%5.68M
-38.17%1.42M
Research and development costs
191.98%3.11M
1,076.15%2.33M
906.89%2.68M
-39.96%3.23M
49.74%1.7M
-30.80%1.07M
-87.02%197.9K
-77.44%265.74K
-78.62%5.38M
23.95%1.13M
Operating profit
-118.14%-4.62M
-197.05%-3.67M
-153.88%-3.91M
25.50%-8.23M
-30.78%-3.34M
27.42%-2.12M
56.81%-1.24M
43.37%-1.54M
66.23%-11.05M
20.46%-2.55M
Net non-operating interest income expense
352.82%658.41K
-26.80%95.69K
-8.34%-7.96K
-439.43%-23.97K
-369.03K
39,187.10%145.4K
9,300.07%130.73K
-184.11%-7.35K
-368.18%-4.44K
0
Non-operating interest income
340.97%664.72K
-25.01%104.88K
----
----
----
--150.74K
221,898.41%139.86K
----
----
----
Non-operating interest expense
18.27%6.31K
0.69%9.19K
8.34%7.96K
439.43%23.97K
--2.15K
1,334.68%5.34K
514.96%9.13K
184.11%7.35K
368.18%4.44K
--0
Other net income (expense)
171.79%654
-16.14%117.45K
5,854.03%547.24K
8,218.20%484.37K
-139.75%-911
45,279.03%140.06K
-96.39%9.19K
371.50%5.82K
Other non- operating income (expenses)
----
171.79%654
-16.14%117.45K
5,854.03%547.24K
8,218.20%484.37K
----
-139.75%-911
45,279.03%140.06K
-96.39%9.19K
371.50%5.82K
Income before tax
-100.84%-3.96M
-223.20%-3.58M
-170.04%-3.8M
30.21%-7.71M
-26.55%-3.23M
32.39%-1.97M
61.33%-1.11M
48.31%-1.41M
65.98%-11.05M
20.61%-2.55M
Income tax
Net income
-100.84%-3.96M
-223.20%-3.58M
-170.04%-3.8M
30.21%-7.71M
-26.55%-3.23M
32.39%-1.97M
61.33%-1.11M
48.31%-1.41M
65.98%-11.05M
20.61%-2.55M
Net income continuous Operations
-100.84%-3.96M
-223.20%-3.58M
-170.04%-3.8M
30.21%-7.71M
-26.55%-3.23M
32.39%-1.97M
61.33%-1.11M
48.31%-1.41M
65.98%-11.05M
20.61%-2.55M
Minority interest income
Net income attributable to the parent company
-100.84%-3.96M
-223.20%-3.58M
-170.04%-3.8M
30.21%-7.71M
-26.55%-3.23M
32.39%-1.97M
61.33%-1.11M
48.31%-1.41M
65.98%-11.05M
20.61%-2.55M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-100.84%-3.96M
-223.20%-3.58M
-170.04%-3.8M
30.21%-7.71M
-26.55%-3.23M
32.39%-1.97M
61.33%-1.11M
48.31%-1.41M
65.98%-11.05M
20.61%-2.55M
Basic earnings per share
97.13%-0.19
54.25%-1.83
74.21%-3.12
94.83%-31.04
83.20%-11.68
96.28%-6.61
97.80%-4
93.00%-12.1
76.21%-600.71
-14.33%-69.51
Diluted earnings per share
97.13%-0.19
54.25%-1.83
74.21%-3.12
94.83%-31.04
83.20%-11.68
96.28%-6.61
97.80%-4
93.00%-12.1
76.21%-600.71
-14.33%-69.51
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 118.14%4.62M197.05%3.67M153.88%3.91M-25.50%8.23M30.78%3.34M-27.42%2.12M-56.81%1.24M-43.37%1.54M-66.23%11.05M-20.46%2.55M
Selling and administrative expenses 43.30%1.51M29.49%1.34M-3.22%1.23M-11.81%5.01M15.63%1.64M-23.65%1.05M-22.37%1.04M-17.33%1.27M-25.14%5.68M-38.17%1.42M
-General and administrative expense 43.30%1.51M29.49%1.34M-3.22%1.23M-11.81%5.01M15.63%1.64M-23.65%1.05M-22.37%1.04M-17.33%1.27M-25.14%5.68M-38.17%1.42M
Research and development costs 191.98%3.11M1,076.15%2.33M906.89%2.68M-39.96%3.23M49.74%1.7M-30.80%1.07M-87.02%197.9K-77.44%265.74K-78.62%5.38M23.95%1.13M
Operating profit -118.14%-4.62M-197.05%-3.67M-153.88%-3.91M25.50%-8.23M-30.78%-3.34M27.42%-2.12M56.81%-1.24M43.37%-1.54M66.23%-11.05M20.46%-2.55M
Net non-operating interest income expense 352.82%658.41K-26.80%95.69K-8.34%-7.96K-439.43%-23.97K-369.03K39,187.10%145.4K9,300.07%130.73K-184.11%-7.35K-368.18%-4.44K0
Non-operating interest income 340.97%664.72K-25.01%104.88K--------------150.74K221,898.41%139.86K------------
Non-operating interest expense 18.27%6.31K0.69%9.19K8.34%7.96K439.43%23.97K--2.15K1,334.68%5.34K514.96%9.13K184.11%7.35K368.18%4.44K--0
Other net income (expense) 171.79%654-16.14%117.45K5,854.03%547.24K8,218.20%484.37K-139.75%-91145,279.03%140.06K-96.39%9.19K371.50%5.82K
Other non- operating income (expenses) ----171.79%654-16.14%117.45K5,854.03%547.24K8,218.20%484.37K-----139.75%-91145,279.03%140.06K-96.39%9.19K371.50%5.82K
Income before tax -100.84%-3.96M-223.20%-3.58M-170.04%-3.8M30.21%-7.71M-26.55%-3.23M32.39%-1.97M61.33%-1.11M48.31%-1.41M65.98%-11.05M20.61%-2.55M
Income tax
Net income -100.84%-3.96M-223.20%-3.58M-170.04%-3.8M30.21%-7.71M-26.55%-3.23M32.39%-1.97M61.33%-1.11M48.31%-1.41M65.98%-11.05M20.61%-2.55M
Net income continuous Operations -100.84%-3.96M-223.20%-3.58M-170.04%-3.8M30.21%-7.71M-26.55%-3.23M32.39%-1.97M61.33%-1.11M48.31%-1.41M65.98%-11.05M20.61%-2.55M
Minority interest income
Net income attributable to the parent company -100.84%-3.96M-223.20%-3.58M-170.04%-3.8M30.21%-7.71M-26.55%-3.23M32.39%-1.97M61.33%-1.11M48.31%-1.41M65.98%-11.05M20.61%-2.55M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -100.84%-3.96M-223.20%-3.58M-170.04%-3.8M30.21%-7.71M-26.55%-3.23M32.39%-1.97M61.33%-1.11M48.31%-1.41M65.98%-11.05M20.61%-2.55M
Basic earnings per share 97.13%-0.1954.25%-1.8374.21%-3.1294.83%-31.0483.20%-11.6896.28%-6.6197.80%-493.00%-12.176.21%-600.71-14.33%-69.51
Diluted earnings per share 97.13%-0.1954.25%-1.8374.21%-3.1294.83%-31.0483.20%-11.6896.28%-6.6197.80%-493.00%-12.176.21%-600.71-14.33%-69.51
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
MicroStrategy
MSTR
+9.03%
Tesla
TSLA
+5.93%
Alphabet-A
GOOGL
+5.52%
Alphabet-C
GOOG
+5.46%
Coinbase
COIN
+3.77%

Unlock the Full List